Download PDF
Planta Med 2014; 80(12): 1009-1016
DOI: 10.1055/s-0034-1382950
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

A Sulfated Cyanobacterial Polysaccharide Proven as a Strong Inhibitor of Human Complement Activity in an In Vitro Assay

Daniela Flamm
Pharmaceutical Institute, Department of Pharmaceutical Biology, Christian-Albrechts-University of Kiel, Kiel, Germany
,
Wolfgang Blaschek
Pharmaceutical Institute, Department of Pharmaceutical Biology, Christian-Albrechts-University of Kiel, Kiel, Germany
› Author Affiliations
Further Information

Publication History

received 04 February 2014
revised 02 June 2014

accepted 07 July 2014

Publication Date:
21 August 2014 (online)

    Permissions and Reprints

Abstract

Cyanobacterial exopolysaccharides are a rich source of, so far, widely unexplored polysaccharides. One of these exopolysaccharides is a highly sulfated, linear polysaccharide from Synechocystis aquatilis containing the amino sugar N-acetyl-fucosamine. Some sulfated polysaccharides and glycosaminoglycans are known to be inhibitors of the human complement system, which is an important part of the innate immune system. Defects in this system or misregulation can cause serious diseases. Therefore, new compounds with complement inhibiting activity and simple test assays are of great interest. Exopolysaccharides from S. aquatilis (arabinofucans) were compared to those from Synechocystis pevalekii (complex heteropolysaccharides) and the well-known complement inhibitor heparin. Investigations were performed with a modified ELISA test system based on a commercially available test kit quantifying the membrane attack complex. Hereby the testing becomes more stable, robust, reproducible, easier to handle and, for the first time, the effect of exopolysaccharides and heparin on the lectin pathway could be tested. The exopolysaccharides from S. aquatilis could be shown to be a 30 times stronger inhibitor of the classical pathway of the complement system compared to heparin (IC50 = 0.3 µg/mL vs. 9.2 µg/mL). These exopolysaccharides are also inhibitors of the lectin pathway (IC50 = 10.8 µg/mL) in which, however, heparin is more potent (IC50 = 2.0 µg/mL). Interestingly, these exopolysaccharides do not inhibit the alternative pathway. The exopolysaccharides from S. pevalekii are inactive in all pathways. Furthermore, partially hydrolyzed and desulfated exopolysaccharides from S. aquatilis were tested showing that a minimum molecular size and degree of sulfation are important for the inhibitory effects, whereas unspecific influences by complex formation of exopolysaccharides with calcium could be excluded.

Key words

cyanobacteria - Synechocystis aquatilis - Synechocystis pevalekii - Merismopediaceae - Chroococcales - exopolysaccharides - sulfated arabinofucan - inhibition of human complement system
 

  • References

  • 1 Pereira S, Zille A, Micheletti E, Moradas-Ferreira P, de Philippis R, Tamagnini P. Complexity of cyanobacterial exopolysaccharides: composition, structures, inducing factors and putative genes involved in their biosynthesis and assembly. FEMS Microbiol Rev 2009; 33: 917-941
    CrossrefPubMedGoogle Scholar
  • 2 Flamm D, Blaschek W. Exopolysaccharides of Synechocystis aquatilis are sulfated arabinofucans containing N-acetyl-fucosamine. Carbohydr Polym 2014; 101: 301-306
    CrossrefPubMedGoogle Scholar
  • 3 Volk RB, Venzke K, Blaschek W, Alban S. Complement modulating and anticoagulant effects of a sulfated exopolysaccharide released by the cyanobacterium Synechocystis aquatilis . Planta Med 2006; 72: 1424-1427
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Ehrnthaller C, Ignatius A, Gebhard F, Huber-Lang M. New insights of an old defense system: structure, function, and clinical relevance of the complement system. Mol Med 2011; 17: 317-329
    PubMedGoogle Scholar
  • 5 Harboe M, Thorgersen EB, Mollnes TE. Advances in assay of complement function and activation. Adv Drug Deliver Rev 2011; 63: 976-987
    CrossrefPubMedGoogle Scholar
  • 6 Kirschfink M, Mollnes TE. Modern complement analysis. Clin Diagn Lab Immun 2003; 10: 982-989
    PubMedGoogle Scholar
  • 7 Tudoran R, Kirschfink M. Moderne Komplementanalytik Indikationen – Methodik – Perspektiven. Laboratoriumsmedizin 2012; 36: 125-134
    PubMedGoogle Scholar
  • 8 Li B, Lu F, Wie X, Zhao R. Fucoidan: structure and bioactivity. Molecules 2008; 13: 1671-1695
    CrossrefPubMedGoogle Scholar
  • 9 Tissot B, Montdargent B, Chevolot L, Varenne A, Descroix S, Gareil P, Daniel R. Interaction of fucoidan with the proteins of the complement classical pathway. Biochim Biophys Acta 2003; 1651: 5-16
    CrossrefPubMedGoogle Scholar
  • 10 Yu H, Muñoz EM, Edens RE, Linhardt RJ. Kinetic studies on the interactions of heparin and complement proteins using surface plasmon resonance. Biochim Biophys Acta 2005; 1726: 168-176
    CrossrefPubMedGoogle Scholar
  • 11 Kolender AA, Matulewicz MC. Desulfation of sulfated galactans with chlorotrimethylsilane. Characterization of beta-carrageenan by 1H NMR spectroscopy. Chin J Oceanol Limn 2004; 339: 1619-1629
    PubMedGoogle Scholar
  • 12 Bilan MI, Zakharova AN, Grachev AA, Shashkov AS, Nifantiev NE, Usov AI. Polysaccharides of algae: 60. Fucoidan from the pacific brown alga Analipus japonicus (Harv.) Winne (Ectocarpales, Scytosiphonaceae). Russ J Bioorg Chem 2004; 33: 38-46
    PubMedGoogle Scholar
  • 13 Valério E, Chaves S, Tenreiro R. Diversity and impact of prokaryotic toxins on aquatic environments: a review. Toxins (Basel) 2010; 2: 2359-2410
    CrossrefPubMedGoogle Scholar
  • 14 Burja AM, Benaigs B, Abou-Mansour E, Burgess JG, Wright PC. Marine cyanobacteria – a profilic source of natural products. Tetrahedron 2001; 57: 9347-9377
    CrossrefPubMedGoogle Scholar
  • 15 Seelen MA, Roos A, Wieslander J, Mollnes TE, Sjöholm AG, Wurzner R, Loos M, Tedesco F, Sim RB, Garred P, Alexopoulos E, Turner MW, Daha MR. Functional analysis of the classical, alternative, and MBL pathways of the complement system: standardization and validation of a simple ELISA. J Immunol Methods 2005; 296: 187-198
    CrossrefPubMedGoogle Scholar
  • 16 Bruell LP, Huang Z, Thomas-Oates JE, Smestad Paulsen B. Studies of polysaccharides from three edible species of Nostoc (cyanobacteria) with different colony morphologies: structural characterization and effect on the complement system of polysaccharides from Nostoc commune . J Phycol 2000; 36: 871-881
    CrossrefPubMedGoogle Scholar
  • 17 Clément MJ, Tissot B, Chevolot L, Adjadj E, Du Y, Curmi PA, Daniel R. NMR characterization and molecular modeling of fucoidan showing the importance of oligosaccharide branching in its anticomplementary activity. Glycobiology 2010; 20: 883-894
    CrossrefPubMedGoogle Scholar
  • 18 Groth I, Grunewald N, Alban S. Pharmacological profiles of animal- and nonanimal-derived sulfated polysaccharides – comparison of unfractionated heparin, the semisynthetic glucan sulfate PS3, and the sulfated polysaccharide fraction isolated from Delesseria sanguine . Glycobiology 2008; 19: 408-417
    CrossrefPubMedGoogle Scholar
  • 19 Uchisawa H, Okuzaki B, Ichita J, Matsue H. Binding between calcium ions and chondroitin sulfate chains of salmon nasal cartilage glycosaminoglycan. Int Congr Ser 2001; 1223: 205-220
    CrossrefPubMedGoogle Scholar
  • 20 Sahu A, Pangburn MK. Identification of multiple sites of interaction between heparin and the complement system. Mol Immunol 1997; 30: 679-684
    PubMedGoogle Scholar
  • 21 Almeda S, Rosenberg RD, Bing DH. The binding properties of human complement component Clq Interaction with mucopolysaccharides. J Biol Chem 1983; 258: 785-791
    PubMedGoogle Scholar
  • 22 Baker KC, Nicklin S, Miller K. The role of carrageenan in complement activation. Food Chem Toxicol 1986; 24: 891-895
    CrossrefPubMedGoogle Scholar
  • 23 Tissot B, Daniel R, Place C. Interaction of the C1 complex of complement with sulfated polysaccharide and DNA probed by single molecule fluorescence microscopy. Eur J Biochem 2003; 270: 4714-4720
    CrossrefPubMedGoogle Scholar
  • 24 Paréj K, Dobó J, Závodszky P, Gál P. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α 2-macroglobulin is not. Mol Immunol 2013; 54: 415-422
    CrossrefPubMedGoogle Scholar
  • 25 Blakeney AB, Harris PJ, Henry R, Stone AB. A simple and rapid preparation of alditol acetates for monosaccharide analysis. Carbohyd Res 1983; 113: 291-299
    CrossrefPubMedGoogle Scholar
  • 26 Goellner EM, Ichinose H, Kaneko S, Blaschek W, Classen B. An arabinogalactan-protein from whole grain of Avena sativa L belongs to the wattle-blossom type of arabinogalactan-proteins. J Cereal Sci 2011; 53: 244-249
    CrossrefPubMedGoogle Scholar
  • 27 Kjeldahl J. A new method for the determination of nitrogen in organic bodies. Z Anal Chem 1883; 22: 366-382
    CrossrefPubMedGoogle Scholar
  • 28 Goellner EM, Blaschek W, Classen B. Structural investigations on arabinogalactan-protein from wheat, isolated with Yariv reagent. J Agr Food Chem 2010; 58: 3621-3626
    CrossrefPubMedGoogle Scholar
  • 29 Blumenkrantz N, Asboe-Hansen G. New method for quantitative determination of uronic acids. Anal Biochem 1973; 54: 484-489
    CrossrefPubMedGoogle Scholar
  • 30 McComb EA, McCready RM. Determination of acetyl in pectin and in acetylated carbohydrate polymers: hydroxamic acid reaction. Anal Chem 1957; 29: 819-821
    CrossrefPubMedGoogle Scholar
  • 31 Sloneker JH, Orentas DG. Pyruvic acid, a unique component of an exocellular bacterial polysaccharide. Nature 1962; 194: 478-479
    CrossrefPubMedGoogle Scholar
  • 32 Goellner EM, Utermoehlen J, Kramer R, Classen B. Structure of arabinogalactan from Larix laricina and its reactivity with antibodies directed against type-II-arabinogalactans. Carbohyd Polym 2011; 86: 1739-1744
    CrossrefPubMedGoogle Scholar
  • 33 Nagasawa K, Inoue Y, Kamata T. Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanol. Carbohyd Res 1977; 58: 47-55
    CrossrefPubMedGoogle Scholar
  • 34 Usov AI, Adamyants KS, Miroshnikova LI, Shaposhnikova AA, Kochetkov NK. Solvolytic desulphation of sulphated carbohydrates. Carbohyd Res 1971; 18: 336-338
    CrossrefPubMedGoogle Scholar